Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Cyclooxygenase type 2, a potential therapeutic target in colon carcinogenesis

Feb. 16, 1998

Weizmann Institute presents new materials for PDT of cancer

Feb. 13, 1998

Nonpeptide GnRH antagonists prepared at Merck & Co.

Feb. 13, 1998

Phase III milestone reached for Ethyol in new indication

Feb. 13, 1998

Antitumor arabinofuranosylcytosines from Yamasa

Feb. 13, 1998

Chiroscience and Bristol-Myers Squibb collaborate on MMP inhibitors for cancer

Feb. 12, 1998

Chinese investigators evaluate new MDR-reversing agent

Feb. 12, 1998

Celltech reports crosslinked antibodies for cancer indications

Feb. 12, 1998

Targeted Genetics to report tgDCC-E1A clinical data

Feb. 11, 1998

Topoisomerase I inhibitor tested in phase I trial

Feb. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...